Monoclonal antibodies in the treatment of colorectal cancer

Angiogenesis in cancer and other diseases

2000 • 8,734 citations

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Cancer Statistics, 2003

2003 • 3,302 citations

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 • 2,777 citations

Epidermal growth factor-related peptides and their receptors in human malignancies

1995 • 2,689 citations

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

2003 • 2,212 citations

Cancer burden in the year 2000. The global picture

2001 • 2,206 citations

EGFR and cancer prognosis

2001 • 2,068 citations

Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

2002 • 1,699 citations

Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins

1992 • 1,612 citations

The EGF receptor family as targets for cancer therapy

2000 • 1,339 citations

Cancer: Principles and Practice of Oncology.

1986 • 1,140 citations

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

2001 • 988 citations

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

2001 • 923 citations

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

1997 • 841 citations

The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy

1999 • 840 citations

Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin

2000 • 748 citations

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

1997 • 638 citations

The biology of the 17–1A antigen (Ep-CAM)

1999 • 541 citations

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1998 • 530 citations

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

2001 • 452 citations

The role of vascular endothelial growth factor in pathological angiogenesis

1995 • 419 citations

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancer

1993 • 415 citations

Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment

2003 • 385 citations

Colorectal cancer

1999 • 312 citations

Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.

1983 • 286 citations

[Cancer of the colon].

1951 • 277 citations

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

2003 • 264 citations

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy

1995 • 243 citations

The fibroblast growth factor family.

1990 • 219 citations

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

2002 • 214 citations

Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence

1998 • 159 citations

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer

1998 • 149 citations

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1

1988 • 122 citations

Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer

2003 • 107 citations

Effect of monoclonal antibody 17‐1A and gm‐CSF in patients with advanced colorectal carcinoma—long‐lasting, complete remissions can be induced

1993 • 101 citations

Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis.

1999 • 92 citations

The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas

1998 • 90 citations

Monoclonal antibodies as therapeutics in oncology

2002 • 84 citations

Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma

2001 • 82 citations

Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity

1989 • 70 citations

Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A)

1988 • 61 citations

Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules.

1990 • 57 citations

CO 17-1A and related monoclonal antibodies: their production and characterization.

1986 • 55 citations

Therapeutics targeting signal transduction for patients with colorectal carcinoma

2002 • 53 citations

Magic Bullets Fly Again

2001 • 47 citations

A phase II trial of murine monoclonal antibody 17-1A and interferon-γ: Clinical and immunological data

1990 • 46 citations

Update of clinical trials with edrecolomab: A monoclonal antibody therapy for colorectal cancer

2001 • 42 citations

Tumor-Associated Antigen Expression of Primary and Metastatic Colon Carcinomas Detected by Monoclonal Antibody 17-1A

1987 • 37 citations

Steigert Körperliche Anstrengung die Disposition zu Epidemischer Kinderlähme

1938 • 23 citations

Antibodies in the therapy of colon cancer.

1999 • 22 citations

DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA

1995 • 15 citations

In vivo activity of humanized monoclonal anti-EGFR antibody EMD72000 in combination with gemcitabine on growth of primary pancreatic tumors and metastases in an orthotopic nude mouse model

2003 • 11 citations

Chemotherapy for colorectal cancer

2002 • 7 citations